ClinicalTrials.gov
public full text
Public Domain
Fasting-Associated Immune-metabolic Remission of Diabetes
People with a body mass index above 28 kg/m² and an onset of type 2 diabetes within the last 4 years had a remission (HbA1c \8 years and oral treatment as primary end points. The immune metabolic programming of circulating monocytes will be investigated in detail regarding trained innate immunity and the endocrine responses will be determined using meal challenge tests.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Biomarkers of Heterogeneity in Type 1 Diabetes#915234
- Natural History of Autoimmune Diabetes and Its Complications#1280042
- TCM and Nutrition for Diabetes Care Cohort#154831
- Innate Immune Function and the Gut Microbiome in Metabolic Dysfunction Associated Steatotic Liver Disease#186514
- Acute effects of the 1-minute sit-to-stand test (STST) on immune-metabolic stress indices.#458635
Record · ID 1442786
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive